S&P 500   3,279.91 (+1.12%)
DOW   28,777.33 (+0.85%)
QQQ   221.47 (+1.55%)
AAPL   317.00 (+2.61%)
FB   218.12 (+1.51%)
MSFT   165.40 (+1.92%)
GOOGL   1,453.26 (+1.50%)
AMZN   1,851.19 (+1.25%)
CGC   22.86 (+6.03%)
NVDA   247.12 (+2.88%)
BABA   209.91 (+2.16%)
MU   56.42 (+1.82%)
GE   11.66 (+1.83%)
TSLA   563.98 (+1.07%)
AMD   50.42 (+2.36%)
T   38.75 (+1.28%)
ACB   1.92 (+1.59%)
F   8.94 (+0.56%)
NFLX   350.16 (+2.12%)
BAC   33.38 (+1.58%)
DIS   138.57 (+1.96%)
GILD   64.54 (+1.10%)
S&P 500   3,279.91 (+1.12%)
DOW   28,777.33 (+0.85%)
QQQ   221.47 (+1.55%)
AAPL   317.00 (+2.61%)
FB   218.12 (+1.51%)
MSFT   165.40 (+1.92%)
GOOGL   1,453.26 (+1.50%)
AMZN   1,851.19 (+1.25%)
CGC   22.86 (+6.03%)
NVDA   247.12 (+2.88%)
BABA   209.91 (+2.16%)
MU   56.42 (+1.82%)
GE   11.66 (+1.83%)
TSLA   563.98 (+1.07%)
AMD   50.42 (+2.36%)
T   38.75 (+1.28%)
ACB   1.92 (+1.59%)
F   8.94 (+0.56%)
NFLX   350.16 (+2.12%)
BAC   33.38 (+1.58%)
DIS   138.57 (+1.96%)
GILD   64.54 (+1.10%)
S&P 500   3,279.91 (+1.12%)
DOW   28,777.33 (+0.85%)
QQQ   221.47 (+1.55%)
AAPL   317.00 (+2.61%)
FB   218.12 (+1.51%)
MSFT   165.40 (+1.92%)
GOOGL   1,453.26 (+1.50%)
AMZN   1,851.19 (+1.25%)
CGC   22.86 (+6.03%)
NVDA   247.12 (+2.88%)
BABA   209.91 (+2.16%)
MU   56.42 (+1.82%)
GE   11.66 (+1.83%)
TSLA   563.98 (+1.07%)
AMD   50.42 (+2.36%)
T   38.75 (+1.28%)
ACB   1.92 (+1.59%)
F   8.94 (+0.56%)
NFLX   350.16 (+2.12%)
BAC   33.38 (+1.58%)
DIS   138.57 (+1.96%)
GILD   64.54 (+1.10%)
S&P 500   3,279.91 (+1.12%)
DOW   28,777.33 (+0.85%)
QQQ   221.47 (+1.55%)
AAPL   317.00 (+2.61%)
FB   218.12 (+1.51%)
MSFT   165.40 (+1.92%)
GOOGL   1,453.26 (+1.50%)
AMZN   1,851.19 (+1.25%)
CGC   22.86 (+6.03%)
NVDA   247.12 (+2.88%)
BABA   209.91 (+2.16%)
MU   56.42 (+1.82%)
GE   11.66 (+1.83%)
TSLA   563.98 (+1.07%)
AMD   50.42 (+2.36%)
T   38.75 (+1.28%)
ACB   1.92 (+1.59%)
F   8.94 (+0.56%)
NFLX   350.16 (+2.12%)
BAC   33.38 (+1.58%)
DIS   138.57 (+1.96%)
GILD   64.54 (+1.10%)
Log in

bluebird bio Price Target & Analyst Ratings (NASDAQ:BLUE)

$84.29
+1.17 (+1.41 %)
(As of 01/28/2020 12:43 PM ET)
Today's Range
$83.51
Now: $84.29
$85.74
50-Day Range
$76.85
MA: $90.25
$98.04
52-Week Range
$71.42
Now: $84.29
$163.43
Volume367,194 shs
Average Volume901,466 shs
Market Capitalization$4.66 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.37

Analyst Ratings

bluebird bio (NASDAQ:BLUE) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
18 Wall Street analysts have issued ratings and price targets for bluebird bio in the last 12 months. Their average twelve-month price target is $134.99, suggesting that the stock has a possible upside of 60.15%. The high price target for BLUE is $195.00 and the low price target for BLUE is $96.00. There are currently 6 hold ratings and 12 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.672.672.582.65
Ratings Breakdown: 0 Sell Rating(s)
6 Hold Rating(s)
12 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
6 Hold Rating(s)
12 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
9 Hold Rating(s)
9 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
8 Hold Rating(s)
11 Buy Rating(s)
1 Strong Buy Rating(s)
Consensus Price Target: $134.99$134.99$148.59$157.21
Price Target Upside: 60.15% upside60.61% upside68.59% upside12.02% upside

bluebird bio (NASDAQ:BLUE) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

bluebird bio (NASDAQ:BLUE) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/19/2020JPMorgan Chase & Co.Reiterated RatingBuyMedium
12/12/2019OppenheimerUpgradeMarket Perform ➝ Outperform$135.00High
12/10/2019William BlairReiterated RatingHoldHigh
12/9/2019Wells Fargo & CoLower Price TargetOverweight$242.00 ➝ $160.00High
12/9/2019Canaccord GenuityLower Price TargetBuy$171.00 ➝ $118.00High
12/6/2019CowenReiterated RatingBuyLow
11/27/2019Evercore ISIDowngradeOutperform ➝ In-LineMedium
11/26/2019Svb LeerinkUpgradeMarket Perform ➝ Outperform$119.00Low
11/26/2019Leerink SwannUpgradeMarket Perform ➝ Outperform$119.00Medium
11/4/2019WedbushUpgradeNeutral ➝ Outperform$131.00 ➝ $124.00High
11/1/2019Stifel NicolausSet Price TargetHold$96.00Low
11/1/2019Morgan StanleySet Price TargetHold$104.00 ➝ $100.00Low
11/1/2019Maxim GroupReiterated RatingBuy$130.00Low
7/19/2019GabelliReiterated RatingBuyN/A
6/17/2019BMO Capital MarketsLower Price TargetOutperform$191.00 ➝ $163.00Low
6/14/2019Piper Jaffray CompaniesSet Price TargetHold$120.00Low
5/16/2019SunTrust BanksLower Price TargetBuy$174.00Medium
3/22/2019Cantor FitzgeraldSet Price TargetHold$122.00Low
12/19/2018Raymond JamesInitiated CoverageStrong-Buy ➝ Strong-Buy$165.00High
12/3/2018Janney Montgomery ScottSet Price TargetOutperform ➝ Buy$170.00High
11/14/2018Sanford C. BernsteinUpgradeMarket Perform ➝ Outperform$155.00High
9/21/2018Goldman Sachs GroupDowngradeConviction-Buy ➝ BuyMedium
9/17/2018GuggenheimInitiated CoverageNeutralMedium
5/3/2018BTIG ResearchReiterated RatingBuyHigh
3/16/2018UBS GroupInitiated CoverageSellHigh
2/22/2018Bank of AmericaBoost Price TargetNeutral ➝ Neutral$185.00 ➝ $218.00Medium
(Data available from 1/28/2018 forward)
This page was last updated on 1/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel